Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism affects many women and is managed with a combination of medical treatments and hair removal, tailored to individual needs.

17b-Estradiol in skin affects hair growth and tumor promotion.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Hair cortisol levels can indicate stress and are affected by washing frequency, not cosmetic treatments.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Hair analysis can track past cortisol levels in Cushing's Syndrome patients.

Hirsutism in teen girls is common, usually harmless, but can sometimes signal serious issues and is treatable.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

Human hair can be used to measure reproductive hormones.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

Effective hirsutism treatment for women with PCOS should be personalized and may include lifestyle changes and medication.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Excessive male hormones in women cause symptoms like unwanted hair growth, and treatment requires careful medical evaluation.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

TCDD changes skin cell growth and keratin production in mice.

Many women with polycystic ovarian disease show symptoms like excessive hair growth, acne, hair loss, and have high levels of certain hormones.

Thyroid-stimulating hormone affects hair follicles but doesn't change hair growth or color.

Adrenal tumors should be considered in Addison's disease if unusual results appear, with surgery as a solution.

Ghrelin and its receptors likely aren't risk factors for PCOS.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Screen young women with menstrual issues, acne, or excess hair for high cortisol to avoid misdiagnosis.

Hair repigmentation can indicate malignancy and should be investigated.